Insiders · INDP

INDP insider transactions

Indaptus Therapeutics Inc. (INDP) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for INDP

• 48d
  SEC Form 3 filed by new insider Lu Qinglai

  3 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 66d
  SEC Form 3 filed by new insider Yao Yun

  3 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 66d
  SEC Form 3 filed by new insider Sino Lion Ventures Ltd

  3 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 66d
  SEC Form 3 filed by new insider Dai Junyi

  3 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 75d
  SEC Form 4 filed by Lazar David E.

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 100d
  SEC Form 4 filed by Director Jabbour Jerome D

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 100d
  SEC Form 3 filed by new insider Jabbour Jerome D

  3 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 101d
  New insider Mcmurdo Matthew Charles claimed ownership of 25,000 shares (SEC Form 3)

  3 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 114d
  SEC Form 4 filed by Co-Chief Executive Officer Meckler Jeffrey A

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 136d
  Director Ben-Tzvi Avraham was granted 25,000 shares, increasing direct ownership by 25,000% to 25,100 units (SEC Form 4)

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 136d
  SEC Form 4 filed by Director Natan David

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 146d
  New insider Natan David claimed no ownership of stock in the company (SEC Form 3)

  3 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 160d
  Chief Operating Officer Linscott Walt Addison was granted 54,421 shares, increasing direct ownership by 1,088,420% to 54,426 units (SEC Form 4)

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 160d
  Co-Chief Executive Officer Meckler Jeffrey A was granted 216,617 shares, increasing direct ownership by 1,627% to 229,929 units (SEC Form 4)

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 160d
  Chief Financial Officer Sassi Nir was granted 26,758 shares (SEC Form 4)

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 160d
  CSO and Director Newman Michael James was granted 52,204 shares, increasing direct ownership by 107% to 101,074 units (SEC Form 4)

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 166d
  New insider Lazar David E. claimed no ownership of stock in the company (SEC Form 3)

  3 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 166d
  New insider Ben-Tzvi Avraham claimed ownership of 100 shares (SEC Form 3)

  3 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 313d
  Chief Executive Officer Meckler Jeffrey A was granted 6,068 shares, increasing direct ownership by 84% to 13,312 units (SEC Form 4)

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 361d
  SEC Form 4 filed by Director Karah Hila

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 361d
  SEC Form 4 filed by Director Martell Robert

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 361d
  SEC Form 4 filed by Director Pomerantz Roger

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 361d
  SEC Form 4 filed by Director Hayes William B

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 361d
  SEC Form 4 filed by Director Maddaluna Anthony J

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 361d
  SEC Form 4 filed by Director Gilbert Mark John

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 558d
  CEO and Director Meckler Jeffrey A was granted 42,553 shares, increasing direct ownership by 27% to 202,859 units (SEC Form 4)

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 605d
  SEC Form 4 filed by CEO and Director Meckler Jeffrey A

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 605d
  SEC Form 4 filed by Chief Operating Officer Linscott Walt Addison

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 605d
  SEC Form 4 filed by CSO and Director Newman Michael James

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 605d
  SEC Form 4 filed by Chief Medical Officer Waltzman Roger J.

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 605d
  SEC Form 4 filed by Chief Financial Officer Sassi Nir

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 668d
  CEO and Director Meckler Jeffrey A was granted 84,932 shares, increasing direct ownership by 113% to 160,306 units (SEC Form 4)

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 730d
  SEC Form 4 filed by Pomerantz Roger

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 730d
  SEC Form 4 filed by Karah Hila

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 730d
  SEC Form 4 filed by Maddaluna Anthony J

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 730d
  SEC Form 4 filed by Gilbert Mark John

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 730d
  SEC Form 4 filed by Martell Robert

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 730d
  SEC Form 4 filed by Hayes William B

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 866d
  SEC Form 4 filed by Newman Michael James

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 866d
  SEC Form 4 filed by Waltzman Roger J.

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 866d
  SEC Form 4 filed by Linscott Walt Addison

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 866d
  SEC Form 4 filed by Meckler Jeffrey A

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 866d
  SEC Form 4 filed by Sassi Nir

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1026d
  SEC Form 4: Anderson Glen R. bought $216,388 worth of shares (103,352 units at $2.09)

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1035d
  SEC Form 4 filed by Waltzman Roger J.

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1035d
  SEC Form 3 filed by new insider Waltzman Roger J.

  3 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1104d
  SEC Form 4 filed by Karah Hila

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1104d
  SEC Form 4 filed by Hayes William B

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1104d
  SEC Form 4 filed by Gilbert Mark John

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1104d
  SEC Form 4 filed by Pomerantz Roger

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1104d
  SEC Form 4 filed by Maddaluna Anthony J

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1209d
  SEC Form 4 filed by Martell Robert

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1209d
  SEC Form 3 filed by new insider Martell Robert

  3 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1234d
  SEC Form 4 filed by Linscott Walt Addison

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1234d
  SEC Form 4 filed by Meckler Jeffrey A

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1234d
  SEC Form 4 filed by Newman Michael James

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1234d
  SEC Form 4 filed by Sassi Nir

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1266d
  SEC Form 4: Litchev Boyan Vesselinov bought $2,520 worth of shares (1,150 units at $2.19)

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1293d
  SEC Form 4: Meckler Jeffrey A bought $18,945 worth of shares (10,000 units at $1.89), increasing direct ownership by 15% to 75,374 units

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1343d
  SEC Form 4 filed by Karah Hila

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)